CUPERTINO, CA -- (Marketwired) -- 07/07/14 --Aemetis, Inc. (NASDAQ: AMTX) announced that the company has received EPA approval for the issuance of D4 RINs upon the importation into the U.S. of biodiesel produced from waste fats and oils (WFO). The EPA also approved the issuance of D6 RINs when biodiesel is produced using other feedstocks. Aemetis built and operates a 50 million gallon per year capacity distilled biodiesel production facility on the East Coast of India.
The superior quality and low carbon intensity biodiesel produced at the Aemetis India plant has recently earned International Sustainability and Carbon Certification (ISCC) Category 2 certification. With the recent construction and commissioning of a biodiesel distillation column at the India plant, the company is producing a colorless biodiesel with 99.5% esters and nearly no monoglycerides, water or other contaminants. Aemetis biodiesel has met and exceeds all D6751 biodiesel specifications, allowing for use in all diesel engines.
"Receiving ISCC Category 2 and EPA certifications are great steps in ramping up India to full capacity with the capability to grow and implement new technologies," said Eric McAfee, Chairman and CEO of Aemetis. "After the successful installation of the India plant distillation unit, in June Aemetis made its first shipment of Category 2 biodiesel to customers in the E.U.," added McAfee.
The India plant was built with the capability to separate oils for food and biodiesel applications. This flexible feedstock processing capability allows the plant to use multiple feedstocks at decreased costs.
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company that was founded in 2006. Aemetis owns and operates a 60 million gallon capacity ethanol and 420,000 ton animal feed plant in California that is the first upgraded facility approved by the EPA to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. Aemetis also built, owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds five granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com
Investor Relations:
Michael Bayes
(415) 389-4670
michaelbayes@liviakis.com
Company Contact:
Todd Waltz
(408) 213-0925
twaltz@aemetis.com
Media Contact:
Melanie Borchardt
(408) 213-0938
mborchardt@aemetis.com
